Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study.

Winter Y, Bezdolnyy Y, Katunina E, Avakjan G, Reese JP, Klotsche J, Oertel WH, Dodel R, Gusev E.

Mov Disord. 2010 Feb 15;25(3):349-56. doi: 10.1002/mds.22966.

Transcranial brain sonography in Parkinson's disease with restless legs syndrome.

Kwon DY, Seo WK, Yoon HK, Park MH, Koh SB, Park KW.

Mov Disord. 2010 Jul 30;25(10):1373-8. doi: 10.1002/mds.23066.

T1rho and T2rho MRI in the evaluation of Parkinson's disease.

Nestrasil I, Michaeli S, Liimatainen T, Rydeen CE, Kotz CM, Nixon JP, Hanson T, Tuite PJ.

J Neurol. 2010 Jun;257(6):964-8. doi: 10.1007/s00415-009-5446-2.

New Vistas on Parkinson's disease.

Willis GL, Armstrong SM.

Eur J Neurol. 2010 Apr;17(4):519-20. doi: 10.1111/j.1468-1331.2009.02852.x. No abstract available.

Parkinson's disease rehabilitation: a pilot study with 1 year follow up.

Frazzitta G, Bertotti G, Uccellini D, Maestri R.

Mov Disord. 2010 Aug 15;25(11):1762-3. doi: 10.1002/mds.23316. No abstract available.

Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.

Cubo E, Martín PM, Martin-Gonzalez JA, Rodríguez-Blázquez C, Kulisevsky J; ELEP Group Members..

Mov Disord. 2010 Jan 15;25(1):70-5. doi: 10.1002/mds.22896.

[Deep brain stimulation and gait disorders in Parkinson disease].

Ferraye MU, Debû B, Pollak P.

Rev Neurol (Paris). 2010 Feb;166(2):178-87. doi: 10.1016/j.neurol.2009.07.018. Review. French.

[Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].

Hol WM, van der Zwaard R, Hovestadt A, van Megen HJ.

Tijdschr Psychiatr. 2010;52(4):259-63. Dutch.

Shortness of breath in a Parkinson's disease patient.

Di Lazzaro V, Pilato F, Granone P, Sestito A, Pirronti T.

Mov Disord. 2010 Dec 15;25(16):2897-8. doi: 10.1002/mds.23367. No abstract available.

Frontiers of science and clinical advances in quality of life in Parkinson's disease. Proceedings of a symposium. October 11-12, 2007.

[No authors listed]

Mov Disord. 2010;25 Suppl 1:S1-179. No abstract available.

Fatigue in Parkinson's disease: prevalence and associated factors.

Beiske AG, Loge JH, Hjermstad MJ, Svensson E.

Mov Disord. 2010 Oct 30;25(14):2456-60. doi: 10.1002/mds.23372.

Calbindin-1 association and Parkinson's disease.

Soto-Ortolaza AI, Behrouz B, Wider C, Vilariño-Güell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farr

Eur J Neurol. 2010 Feb;17(2):208-11. doi: 10.1111/j.1468-1331.2009.02769.x.

Parkin and Parkinson's disease: differentiated by non-dopaminergic dysfunction?

Stoessl AJ.

Exp Neurol. 2010 Sep;225(1):48-50. doi: 10.1016/j.expneurol.2010.04.015. Review. No abstract available.

The effect of L-Dopa administration on pursuit ocular movements in suspected Parkinson's disease.

Marino S, Lanzafame P, Sessa E, Bramanti A, Bramanti P.

Neurol Sci. 2010 Jun;31(3):381-5. doi: 10.1007/s10072-009-0180-1.

Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease.

Luchetti S, Bossers K, Frajese GV, Swaab DF.

Brain Pathol. 2010 Sep;20(5):945-51. doi: 10.1111/j.1750-3639.2010.00396.x.